Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We employ our advanced, specialised process to create targeted libraries.
Fig. 1. The sreening workflow of Receptor.AI
Utilising molecular simulations, our approach thoroughly examines a wide array of proteins, tracking their conformational changes individually and within complexes. Ensemble virtual screening enables us to address conformational flexibility, revealing essential binding sites at functional regions and allosteric locations. Our rigorous analysis guarantees that no potential mechanism of action is overlooked, aiming to uncover new therapeutic targets and lead compounds across diverse biological functions.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
P51671
UPID:
CCL11_HUMAN
Alternative names:
C-C motif chemokine 11; Eosinophil chemotactic protein; Small-inducible cytokine A11
Alternative UPACC:
P51671; P50877; Q92490; Q92491
Background:
Eotaxin, also known as C-C motif chemokine 11, plays a pivotal role in allergic reactions by promoting eosinophil accumulation. It achieves this through binding to the CCR3 receptor, highlighting its significance in immune response mechanisms.
Therapeutic significance:
Understanding the role of Eotaxin could open doors to potential therapeutic strategies, especially in the context of allergic inflammatory reactions where eosinophil regulation is crucial.